Pregnancies after vaginal radical trachelectomy (RT) in patients with early invasive uterine cervical cancer: results from a single institute.


Journal

BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799

Informations de publication

Date de publication:
25 Apr 2020
Historique:
received: 07 12 2019
accepted: 14 04 2020
entrez: 27 4 2020
pubmed: 27 4 2020
medline: 17 12 2020
Statut: epublish

Résumé

Radical tracheletomy (RT) with pelvic lymphadenectomy has become an option for young patients with early invasive uterine cervical cancer who desire to maintain their fertility. However, this operative method entails a high risk for the following pregnancy due to its radicality. We have performed vaginal RT for 71 patients and have experienced 28 pregnancies in 21 patients. They were followed up carefully according to the follow-up methods we reported previously. Their pregnancy courses and prognoses after the pregnancy were retrospectively reviewed. All the vaginal RTs were performed safely without serious complications, including 6 patients who underwent the operation during pregnancy. The median time to be pregnant after RT was 29.5 months. 13 patients (46%) became pregnant without artificial insemination by husband or assisted reproductive technology. Cesarean section was performed for all of them. The median time of pregnancy was 34 weeks, and emergent cesarean section was performed for 7 pregnancies (25%). The median birth weight was 2156 g. Four patients had trouble with cervical cerclage, and they suffered from sudden premature preterm rupture of the membrane (pPROM) during the second trimester of pregnancy. We underwent transabdominal cerclage (TAC) for all of them and careful management for the prevention of uterine infection was performed. One patient had a recurrence of cancer during pregnancy. Both the obstetrical prognosis and oncological prognosis after vaginal RT have become favorable for pregnant patients after vaginal RT.

Sections du résumé

BACKGROUND BACKGROUND
Radical tracheletomy (RT) with pelvic lymphadenectomy has become an option for young patients with early invasive uterine cervical cancer who desire to maintain their fertility. However, this operative method entails a high risk for the following pregnancy due to its radicality.
METHODS METHODS
We have performed vaginal RT for 71 patients and have experienced 28 pregnancies in 21 patients. They were followed up carefully according to the follow-up methods we reported previously. Their pregnancy courses and prognoses after the pregnancy were retrospectively reviewed.
RESULTS RESULTS
All the vaginal RTs were performed safely without serious complications, including 6 patients who underwent the operation during pregnancy. The median time to be pregnant after RT was 29.5 months. 13 patients (46%) became pregnant without artificial insemination by husband or assisted reproductive technology. Cesarean section was performed for all of them. The median time of pregnancy was 34 weeks, and emergent cesarean section was performed for 7 pregnancies (25%). The median birth weight was 2156 g. Four patients had trouble with cervical cerclage, and they suffered from sudden premature preterm rupture of the membrane (pPROM) during the second trimester of pregnancy. We underwent transabdominal cerclage (TAC) for all of them and careful management for the prevention of uterine infection was performed. One patient had a recurrence of cancer during pregnancy.
CONCLUSIONS CONCLUSIONS
Both the obstetrical prognosis and oncological prognosis after vaginal RT have become favorable for pregnant patients after vaginal RT.

Identifiants

pubmed: 32334568
doi: 10.1186/s12884-020-02949-1
pii: 10.1186/s12884-020-02949-1
pmc: PMC7183613
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

248

Références

BJOG. 2001 Aug;108(8):882-5
pubmed: 11510717
Semin Perinatol. 2017 Nov;41(7):392-400
pubmed: 28823578
Int J Gynecol Cancer. 2016 Jan;26(1):163-8
pubmed: 26512787
Gynecol Oncol. 2011 May 1;121(2):290-7
pubmed: 21255824
J Obstet Gynaecol Res. 2016 Jul;42(7):876-82
pubmed: 27074963
Gynecol Oncol. 2013 Oct;131(1):77-82
pubmed: 23769758
Int J Clin Oncol. 2013 Dec;18(6):1085-90
pubmed: 23053400
BJOG. 2019 Aug;126(9):1169-1174
pubmed: 30663205
Obstet Gynecol. 1992 Aug;80(2):173-7
pubmed: 1635726
Hum Reprod. 2013 Jul;28(7):1793-8
pubmed: 23624633
Reprod Med Biol. 2018 May 06;17(3):297-306
pubmed: 30013432
J Obstet Gynaecol Res. 2018 Jan;44(1):61-66
pubmed: 29121417
Cancer. 2000 Apr 15;88(8):1877-82
pubmed: 10760765
Gynecol Oncol. 2008 Aug;110(2):168-71
pubmed: 18539313
Int J Clin Oncol. 2011 Apr;16(2):141-4
pubmed: 21086011
Int J Clin Oncol. 2014 Oct;19(5):906-11
pubmed: 24170246
Am J Obstet Gynecol. 2018 Nov;219(5):461.e1-461.e18
pubmed: 30138618
JAAPA. 2017 Dec;30(12):15-21
pubmed: 29135564
Clin Case Rep. 2019 Aug 30;7(10):1939-1944
pubmed: 31624613
Int J Gynecol Cancer. 2017 Jun;27(5):1021-1027
pubmed: 28498240
N Engl J Med. 1988 Oct 13;319(15):972-8
pubmed: 3262199
Postgrad Med. 2019 Jan;131(1):8-18
pubmed: 30424704
Int J Clin Oncol. 2017 Apr;22(2):340-346
pubmed: 27804040
Gynecol Oncol. 2011 Mar;120(3):321-5
pubmed: 21320670
J Obstet Gynaecol Res. 2019 Jun;45(6):1167-1172
pubmed: 31044479
Int J Gynecol Cancer. 2011 Dec;21(9):1635-9
pubmed: 21795986

Auteurs

Shota Shinkai (S)

Department of Obstetrics and Gynecology, Sapporo Medical University, S1, W16, Chuou-ku, Sapporo, Hokkaido, 0608543, Japan.

Shinichi Ishioka (S)

Department of Obstetrics and Gynecology, Sapporo Medical University, S1, W16, Chuou-ku, Sapporo, Hokkaido, 0608543, Japan. ishioka000@yahoo.co.jp.

Tasuku Mariya (T)

Department of Obstetrics and Gynecology, Sapporo Medical University, S1, W16, Chuou-ku, Sapporo, Hokkaido, 0608543, Japan.

Yuya Fujibe (Y)

Department of Obstetrics and Gynecology, Sapporo Medical University, S1, W16, Chuou-ku, Sapporo, Hokkaido, 0608543, Japan.

Miseon Kim (M)

Department of Obstetrics and Gynecology, Sapporo Medical University, S1, W16, Chuou-ku, Sapporo, Hokkaido, 0608543, Japan.

Masayuki Someya (M)

Department of Obstetrics and Gynecology, Sapporo Medical University, S1, W16, Chuou-ku, Sapporo, Hokkaido, 0608543, Japan.

Tsuyoshi Saito (T)

Department of Obstetrics and Gynecology, Sapporo Medical University, S1, W16, Chuou-ku, Sapporo, Hokkaido, 0608543, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH